Evaluation of the clinical safety and efficacy of iobitridol (Xenetix) in intravenous urography

European Journal of Radiology

Volumn 23, Issue 3, 1996, Pages 185-189

  Fournier, P J ^a   Steinbrich, W ^a   Freitag, P ^a   Voegeli, E ^b  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b Kantonsspital ^*  (Switzerland)

Author keywords

efficacy; intravenous urography; iobitridol; iohexol; iopamidol; safety

Indexed keywords

IOBITRIDOL; IOHEXOL; IOPAMIDOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; INTRAVENOUS UROGRAPHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

CONTRAST MEDIA; FEMALE; HUMANS; IOHEXOL; IOPAMIDOL; MALE; MIDDLE AGED; SAFETY; UROGRAPHY;

EID: 0030293891     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0720-048X(96)01083-2     Document Type: Article

References (10)

1. [1] Elke M. Kontrastmittel in der Röntgenendiagnostik, 2 Auage. Stuttgart: Thieme Verlag, 1992.
2. [2] Lawrence V, Matthai W, Hartmaier S. Comparative safety of high-osmolality radiographic contrast agents. Report of a multidisciplinary working group, report. Invest Radiol 1992; 27: 2-28.
3. [3] Rapoport SI, Leviten H. Neurotoxicity of X-ray contrast media: relation to lipid solubility and blood brain barrier permeability. Am J Roentgenol 1974; 122: 186-193.
4. [4] Sovak M. Introduction: State of the art and design principle of contrast media. In: Sovak M, editor. Radiocontrast Agents. Berlin: Springer Verlag, 1984; 1-22.
5. [5] Maiss L, Van Waes PFGM, Bakker AJ, Falke THM. Evaluation of the clinical safety and efficacy of Iobitridol a new non-ionic iodine contrast agent in intravenous urography. Communication at European Symposion on Uroradiology, Florence, September 12-15th, 1994.
6. [6] Deray G, Bellin MF, Raymond F, Zaim S, Grellet J. Renal tolerance of Iobitridol (XENETIX) a new non-ionic contrast agent in high risk patients. Communication at European Symposion on Uroradiology, Florence, September 12-15th, 1994.
7. [7] Speck U, Siefert HM, Klink G. Contrast media and pain in peripheral arteriography. Invest Radiol 1980; 15: 335-339.
8. [8] Lagroye I, Lakhdar B, Potier M, Cambar J, Intérêt des cultures cellulaires pour apprécier la cytotoxicité comparative des produits de contraste. Congrès CERF, Paris, 23-25 Septembre, 1994.
9. [9] Meyer D, Fouchet MH, Petta M. Stabilité conformationnelle de la sphère hydrophile des non-ioniques triiodés: application au iobitridol. Revue d'Imagerie Médicale 1994; 6(10): 100.
10. [10] Bourrinet P, Chambon C, Cochet P, Bromet-Petit M, Bonnemain B. Etude de la biodistribution du iobitridol par autoradiographie quantitative chez le rat. Revue d'Imagerie Médicale 1994; 6(10): 96.